D. Bishop-Bailey

J. Mitchell, T. Warner, T. Hla, 2002, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

AGONIST-DEPENDENT UTILISATION OF NAD plus FOR METABOLIC REGULATION OF TUBULOGENESIS BY HUMAN ENDOTHELIAL CELLS

C. Carr, D. Bishop-Bailey, A. Faulkner, 2015 .

Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells

D. Zeldin, M. Edin, F. Lih, 2014, Biochemical and biophysical research communications.

Inducible CYP 2 J 2 and Its Product 11 , 12-EET Promotes Bacterial Phagocytosis : A Role for CYP 2 J 2 Deficiency in the Pathogenesis of Crohn ’ s Disease ?

D. Gilroy, D. Zeldin, M. Edin, 2018 .

Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids

D. Zeldin, M. Edin, F. Lih, 2020, Cells.

Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins

M. Yaqoob, D. Gilroy, D. Zeldin, 2015, Biochemical and biophysical research communications.

Dissecting the role of eosinophil cationic protein in upper airway disease

Smita Y. Patel, Smita Y Patel, D. Bishop-Bailey, 2012, Current opinion in allergy and clinical immunology.

Characterization of the induction of nitric oxide synthase and cyclo‐oxygenase in rat aorta in organ culture

T. Warner, Gong Chen, D. Bishop-Bailey, 1997, British journal of pharmacology.

Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells.

J. Pepper, T. Evans, T. Warner, 1998, Journal of cardiovascular pharmacology.

A thin layer angiogenesis assay: a modified basement matrix assay for assessment of endothelial cell differentiation

W. Hall, D. Bishop-Bailey, A. Hibbert, 2014, BMC Cell Biology.

Endogenous Epoxygenases Are Modulators of Monocyte/Macrophage Activity

D. Gilroy, T. Warner, M. Holness, 2011, PloS one.

Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation

J. Mitchell, T. Warner, D. Zeldin, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist.

T. Warner, D. Bishop-Bailey, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Meridianin C inhibits the growth of YD‐10B human tongue cancer cells through macropinocytosis and the down‐regulation of Dickkopf‐related protein‐3

M. Noguchi, J. Kano, I. Jang, 2018, Journal of cellular and molecular medicine.

Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells.

J. Mitchell, T. Warner, E. Wood, 2003, Molecular pharmacology.

Role for Nuclear Factor- (cid:1) B and Signal Transducer and Activator of Transcription 1/Interferon Regulatory Factor-1 in Cytokine-Induced Endothelin-1 Release in Human Vascular Smooth Muscle Cells

T. Warner, E. Wood, D. Bishop-Bailey, 2003 .

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.

M. Kondo, T. Hla, A. Hashiramoto, 2000, The Journal of clinical investigation.

The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.

Julian R. E. Davis, D. Berney, R. Quinton, 2008, The Journal of clinical endocrinology and metabolism.

Cyclooxygenase-1 and -2 isoenzymes.

C. H. Liu, T. Hla, O. Trifan, 1999, The international journal of biochemistry & cell biology.

Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ

F. Ali, M. Paul-Clark, T. Warner, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

From the raw bar to the bench: Bivalves as models for human health

Rebecca J. Stevick, M. Gerdol, M. Gómez-Chiarri, 2019, Developmental and comparative immunology.

Peroxisome proliferator-activated receptors and inflammation.

D. Bishop-Bailey, L. A. Moraes, L. Piqueras, 2006, Pharmacology & therapeutics.

A Role for PPARβ/δ in Ocular Angiogenesis

D. Bishop-Bailey, 2008, PPAR research.

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

J. Vane, D. Willoughby, J. Croxtall, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Nitric Oxide Synthesis and Actions

J. Mitchell, D. Bishop-Bailey, 2000 .

Aspirin and the in vitro linear relationship between thromboxane A2‐mediated platelet aggregation and platelet production of thromboxane A2

F. Ali, M. Paul-Clark, T. Warner, 2008, Journal of thrombosis and haemostasis : JTH.

Molecular dynamics simulations of the interaction of wild type and mutant human CYP2J2 with polyunsaturated fatty acids

D. Bishop-Bailey, K. Abelak, I. Nobeli, 2019, BMC Research Notes.

The platelet as a model system for the acute actions of nuclear receptors

D. Bishop-Bailey, 2010, Steroids.

15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

M. Kondo, T. Hla, A. Hashiramoto, 2000 .

Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation.

J. Wray, D. Bishop-Bailey, 2003, Prostaglandins & other lipid mediators.

The Role of PPARs in the Endothelium: Implications for Cancer Therapy

D. Bishop-Bailey, K. Swales, 2008, PPAR research.

Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.

D. Bishop-Bailey, J. Bystrom, 2009, Pharmacology & therapeutics.

A thin layer angiogenesis assay: a modified basement matrix assay for assessment of endothelial cell differentiation

D. Bishop-Bailey, A. Hibbert, A. Faulkner, 2014, BMC Cell Biology.

Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release

J. Mitchell, M. Perretti, L. Norling, 2009, Journal of leukocyte biology.

Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.

J. Redondo, T. Warner, A. Reynolds, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.

N. Patel, C. Thiemermann, M. Yaqoob, 2010, American journal of respiratory and critical care medicine.

Mechanisms governing the health and performance benefits of exercise

D. Bishop-Bailey, 2013, British journal of pharmacology.

Epoxygenases and peroxisome proliferator‐activated receptors in mammalian vascular biology

J. Wray, D. Bishop-Bailey, 2008, Experimental physiology.

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.

M. Korbonits, T. Warner, D. Bishop-Bailey, 2006, Cancer research.

PPARs and angiogenesis.

D. Bishop-Bailey, 2011, Biochemical Society transactions.

Tumour vascularisation: a druggable target.

D. Bishop-Bailey, 2009, Current opinion in pharmacology.

Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 *

T. Hla, D. Bishop-Bailey, 1999, The Journal of Biological Chemistry.

Expression and activation of the farnesoid X receptor in the vasculature.

T. Warner, D. Bishop-Bailey, D. T. Walsh, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Genome to phenome tools: In vivo and in vitro transfection of Crassostrea virginica hemocytes.

N. Poulton, D. Bishop-Bailey, José A. Fernández Robledo, 2020, Fish and Shellfish Immunology.

PPARγ ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator‐activated receptor‐γ antagonist

T. Warner, D. Bishop-Bailey, 2003 .

Interactions between CKD and MetS and the Development of CVD

K. Aihara, M. Mogi, Xinliang Ma, 2011, Cardiology research and practice.

Cyclo-oxygenase-2 in vascular smooth muscle.

T. Hla, D. Bishop-Bailey, J. Mitchell, 1999, International journal of molecular medicine.

Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells.

J. Pepper, D. Bishop-Bailey, P. Hellewell, 1998, Biochemical and biophysical research communications.

Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.

T. Hla, Y. Kawahito, D. Bishop-Bailey, 2001, Anticancer research.

Cyclooxygenases 1, 2, and 3 and the Production of Prostaglandin I2: Investigating the Activities of Acetaminophen and Cyclooxygenase-2-Selective Inhibitors in Rat Tissues

J. Mitchell, T. Warner, D. Bishop-Bailey, 2004, Journal of Pharmacology and Experimental Therapeutics.

PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status.

M. Holness, M. Sugden, D. Bishop-Bailey, 2011, The Biochemical journal.

Non-genomic signalling of the retinoic X receptor through inhibition of Gq signalling in human platelets

D. Bishop-Bailey, J. Gibbins, L. A. Moraes, 2007 .

Nuclear Receptors in Vascular Biology

D. Bishop-Bailey, 2015, Current Atherosclerosis Reports.

Computational modelling of the binding of arachidonic acid to the human monooxygenase CYP2J2

D. Bishop-Bailey, A. Macchiarulo, K. Abelak, 2016, Journal of Molecular Modeling.

FXR as a novel therapeutic target for vascular disease.

D. Bishop-Bailey, 2004, Drug news & perspectives.

ReviewArticle The Role of PPARs in the Endothelium: Implications for Cancer Therapy

D. Bishop-Bailey, K. Swales, 2008 .

The potential use of the pregnane X receptor in cardiovascular therapy

D. Bishop-Bailey, K. Swales, 2012, Expert review of cardiovascular therapy.

SMOOTH MUSCLE CELLS | Vascular

D. Bishop-Bailey, K. Swales, 2006 .

Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.

Garret A FitzGerald, Béatrice Desvergne, W. Wahli, 2006, American journal of respiratory cell and molecular biology.

Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line

T. Warner, T. Hla, D. Bishop-Bailey, 2000, British journal of pharmacology.

COX-2 in cardiovascular disease.

J. Mitchell, T. Warner, D. Bishop-Bailey, 2006, Arteriosclerosis, thrombosis, and vascular biology.

PPARβ/δ a potential target in pulmonary hypertension blighted by cancer risk

J. Mitchell, D. Bishop-Bailey, 2018, Pulmonary circulation.

PPARs and angiogenesis.

D. Bishop-Bailey, 2011, Biochemical Society transactions.

Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.

D. Bishop-Bailey, J. Bystrom, 2009, Pharmacology & therapeutics.

Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets

T. Warner, J. Wray, D. Bishop-Bailey, 2007, Blood.

Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells

D. Zeldin, M. Edin, F. Lih, 2014, Biochemical and biophysical research communications.

Influence of plasma protein on the potencies of inhibitors of cyclooxygenase‐1 and ‐2

J. Mitchell, T. Warner, D. Bishop-Bailey, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.